)
Boston Scientific (BSX) investor relations material
Boston Scientific AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting held virtually to engage stockholders globally, with agenda and rules posted online.
Voting instructions and Q&A procedures explained at the outset.
Safe harbor reminder for forward-looking statements provided.
Board and executive committee updates
Board members standing for re-election introduced, including notable industry leaders.
Two long-serving board members, Yoshiaki Fujimori and John Sununu, retired and were acknowledged for their service.
Ernst & Young representatives present as independent auditors.
Financial performance review
Achieved $20 billion in net sales for 2025, with mid-teens growth rate.
Over $2 billion invested in R&D, expanding reach to 127 countries and treating over 48 million patients.
Venture capital portfolio includes 45+ active investments, supporting pipeline and future acquisitions.
- Q1 2026 delivered double-digit sales growth, strong EPS, and major acquisitions amid segment headwinds.BSX
Q1 20261 May 2026 - $15B acquisition expands into high-growth vascular markets, targeting double-digit EPS growth.BSX
M&A announcement14 Apr 2026 - Double-digit sales and EPS growth in 2025; 2026 outlook strong with innovation and margin expansion.BSX
Q4 202513 Apr 2026 - Clinical trial successes and innovation pipeline support major market and guideline expansion.BSX
American College of Cardiology 75th Annual Scientific Session and Expo29 Mar 2026 - 2025 performance exceeded targets, driving pay-for-performance and governance reforms.BSX
Proxy Filing18 Mar 2026 - Board recommends director elections, compensation approval, and expanded shareholder rights.BSX
Proxy Filing18 Mar 2026 - Shareholders to vote on director elections, executive pay, auditor, and major governance changes.BSX
Proxy Filing6 Mar 2026 - Double-digit growth, innovation in EP/PFA, and portfolio expansion drive strong outlook.BSX
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Q2 net sales up 14.5% to $4.12B, adjusted EPS $0.62, and guidance raised for 2024.BSX
Q2 20243 Feb 2026
Next Boston Scientific earnings date
Next Boston Scientific earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage